IDN 5390: an oral taxane candidate for protracted treatment schedules

The recognition of the antiangiogenic properties of taxanes provides a basis for novel therapeutic approaches. A prolonged exposure to low drug concentrations has been proposed to be the most suitable approach to exploit the antiangiogenic potential of cytotoxic agents. Such schedule is required to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratesi, G, Laccabue, D, Lanzi, C, Cassinelli, G, Supino, R, Zucchetti, M, Frapolli, R, D'Incalci, M, Bombardelli, E, Morazzoni, P, Riva, A, Zunino, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377083/
https://www.ncbi.nlm.nih.gov/pubmed/12644838
http://dx.doi.org/10.1038/sj.bjc.6600784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377083/
https://www.ncbi.nlm.nih.gov/pubmed/12644838
http://dx.doi.org/10.1038/sj.bjc.6600784

Ejemplares similares